Skip to main content
MedoxyMedoxyHealthcare Pvt Ltd
Pharmaceutical trading & distribution

Advancing healthcare throughtrusted partnerships.

Medoxy connects healthcare professionals and distribution partners with a focused gastroenterology portfolio, dependable documentation, and responsive trade support.

Start a partnershipExplore products
B2B catalogueInquiry-led supportProduct-specific review
Clinical visualization of the digestive system representing Medoxy's gastroenterology portfolio

Featured portfolio

Gastroenterology

1

Therapeutic Divisions

14

Product Catalogue Entries

7

Listed Categories

5

Listed Dosage Forms

Hospitals & Clinics
Healthcare Institutions
Medical Professionals
Distribution Partners

Why Medoxy

Built for serious healthcare conversations.

The site structures product discovery, documentation questions, and the next qualified business conversation.

01

Documentation first

Clear product, composition, packaging, and sourcing information for confident evaluation.

02

Evidence aware

Product and trade questions framed around scope, current records, and the proposed market.

03

Partnership focused

A direct inquiry route for distributors, healthcare organizations, and institutions.

Focused portfolio

Gastroenterology products, clearly presented.

View full portfolio
Benzispa SR pharmaceutical product packaging

Gastroenterology / Antispasmodic

Benzispa SR

Mebeverine Hydrochloride Sustained Release

B2B catalogue entry for a sustained-release capsule listed with mebeverine hydrochloride; qualified buyers may request current product and market documents, subject to applicability and availability.

View product
Benzispa Plus pharmaceutical product packaging

Gastroenterology / Antispasmodic

Benzispa Plus

Mebeverine + Chlordiazepoxide

B2B catalogue entry for a tablet listed with mebeverine and chlordiazepoxide, presented for qualified product-document and trade inquiries.

View product
Esomizole-D pharmaceutical product packaging

Gastroenterology / Acidity & GERD

Esomizole-D

Esomeprazole (EC) + Domperidone (SR)

B2B catalogue entry for a capsule listed with enteric-coated esomeprazole and sustained-release domperidone, subject to document and market review.

View product

How we work

A clearer path from inquiry to partnership.

Our process is designed to keep commercial conversations focused, informed, and efficient.

Discuss your requirements
01

Share your requirement

Tell us your product interest, market, and business needs.

02

Review the portfolio

Compare the listed catalogue fields and identify the records needed for your decision.

03

Clarify the next step

Medoxy can confirm what information is applicable and available for the defined request.

Industry perspective

Insights for modern healthcare partnerships.

Explore all insights
Distribution Quality

Building Trust in Pharmaceutical Distribution

A B2B framework for evaluating identity, records, storage requirements, traceability, and escalation readiness across a medicine supply relationship.

Read article
Quality Systems

Quality Systems for Modern Healthcare Brands

How B2B healthcare teams can turn quality language into scoped evidence, controlled records, vendor questions, and accountable follow-up.

Read article
Catalogue Evaluation

Gastroenterology Catalogue Evaluation for B2B Sourcing

A non-clinical method for navigating categories, comparing listed product attributes, and defining the documents needed for a qualified sourcing review.

Read article

Let's move healthcare forward

Ready to discuss your next pharmaceutical opportunity?

Send an inquiry

Medoxy Healthcare Pvt Ltd is a B2B pharmaceutical trading company based in Gurgaon, Haryana, India, focused on a gastroenterology product catalogue for distributors, stockists, hospitals, institutions, and other qualified healthcare businesses. The product catalogue lists brand names, compositions, dosage forms, and pack sizes across categories such as proton pump inhibitor combinations, antispasmodics, ursodeoxycholic acid, rifaximin, probiotics, antacid and alginate suspensions, and nutritional supplements.

Catalogue entries include Benzispa SR (Mebeverine Hydrochloride Sustained Release), Benzispa Plus (Mebeverine + Chlordiazepoxide), Esomizole-D (Esomeprazole (EC) + Domperidone (SR)), Ursofiz 300 (Ursodeoxycholic Acid IP 300 mg), Ushield (Sucralfate + Oxetacaine), Esomizole-40 (Esomeprazole 40 mg with Sodium Bicarbonate as buffer), Edoflora (Lyophilized Saccharomyces boulardii 250 mg), Menzovit (Multivitamin, Multimineral, Antioxidants, Iron & Zinc), Finozyme Q10 (Coenzyme Q10 + L-Arginine + Omega-3 fatty acid + Selenium + Lycopene), Esomizole-IT (Esomeprazole (EC) + Itopride (SR)), Ursofiz 450 (Ursodeoxycholic Acid Sustained Release), U Raft (Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate), Rifadoxy 400 (Rifaximin IP 400 mg) and Rifadoxy 550 (Rifaximin IP 550 mg). Names, compositions, images, packaging, and availability may change or differ by market. Verify the exact product and current documents before any regulatory, procurement, or commercial decision.

1. Website content is provided for business and informational purposes only and is not a substitute for professional medical advice, diagnosis, treatment, or approved prescribing information. Patients should consult a qualified healthcare professional.

2. This website does not sell medicines online, display pricing, or accept consumer orders. A listing or inquiry response is not an offer of supply or a guarantee of availability. Terms apply.

3. References to quality, compliance, or external guidelines do not by themselves establish a particular licence, approval, or certification. Evidence applicable to a defined transaction can be requested through the trade inquiry form. See Trade & Quality and Compliance for more information.

Articles on the Healthcare Insights blog follow our content policy. Personal data submitted through inquiry forms is handled as described in the privacy policy.